Effect of a Plant Based Nootropic on Perceptual Decision Making.
NCT06689644 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37
Last updated 2024-11-14
Summary
Nootropics are a group of medicinal substances purported to improve important cognitive functions such as learning, focus and memory. Many of these substances have demonstrated beneficial effects on cognitive performance and overall health. However, a thorough understanding of how these substances and their synergistic effects in the form of a supplement may benefit fundamental brain processes is currently lacking. In the current study, we will investigate the effects of a plant-based, nootropic supplement (https://uk.mindlabpro.com/) on perceptual decision-making (i.e. the ability to make rapid decisions based on sensory stimuli) in healthy adult participants.
Conditions
- Cognitive Enhancement
Interventions
- DIETARY_SUPPLEMENT
-
Nootropics (ginkgo biloba, nicergoline, piracetam, or others)
Commercially available product: Mind lab pro
- DIETARY_SUPPLEMENT
-
Placebo
A cellulose commonly used as a bulking agent in supplement products
- BEHAVIORAL
-
Perceptual decision-making performance
A computerised cognitive task involving rapid visual categorisation of images
- DEVICE
-
Electroencephalography
Brain signals are recorded from a 64 channel EEG system during the cognitive task
Sponsors & Collaborators
-
University of Leeds
lead OTHER
Principal Investigators
-
Ioannis Delis · University of Leeds
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-23
- Primary Completion
- 2024-03-06
- Completion
- 2024-06-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Eriobotyra Japonica Lindley Extract on Improvement of Cognitive Function
NCT01734200 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
NCT00446485 ·Status: COMPLETED ·Phase: PHASE4
-
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
NCT04078178 ·Status: COMPLETED ·Phase: NA
-
Efficacy of MEMORMAX in Subjects With MCI
NCT03581929 ·Status: COMPLETED ·Phase: NA
-
Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI
NCT01046292 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment
NCT03780621 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Fermented Codonopsis Lanceolata on Improvement in Cognitive-Bio-Markers of Cognitive Functions
NCT03439098 ·Status: COMPLETED ·Phase: NA
-
Effect of BrainPhyt, a Microalgae Based Ingredient on Cognitive Function in Healthy Older Subjects
NCT04832412 ·Status: COMPLETED ·Phase: NA
-
Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
NCT04121728 ·Status: UNKNOWN ·Phase: NA
-
Ginkgo Biloba Prevention Trial in Older Individuals
NCT00010803 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 ·Status: RECRUITING ·Phase: NA
-
Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient
NCT05690724 ·Status: RECRUITING ·Phase: NA
-
Cognitive Effects of Citicoline on Attention in Healthy Mean and Women
NCT04967157 ·Status: COMPLETED ·Phase: NA
-
Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine
NCT01009476 ·Status: COMPLETED
-
Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
NCT04213391 ·Status: UNKNOWN ·Phase: NA
-
Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline
NCT03094546 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
NCT01073228 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Qualia Mind on Cognition in a Healthy Population
NCT04389723 ·Status: COMPLETED ·Phase: NA
-
To Access the Effect of Brain Pill™ on Working Memory Capacity and Mood Behaviour.
NCT03198936 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
NCT01689233 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
NCT06761066 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Preventing Cognitive Decline With Alternative Therapies
NCT00010920 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects
NCT02342041 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment
NCT02982603 ·Status: COMPLETED ·Phase: PHASE4